Searched for
RESHAPE LIFESCIENCES
Novo Nordisk’s weight-loss drug patent loss sparks a ‘gold rush’ for generic drugmakersIndia's weight-loss drug market is seeing a major shift. Generic versions of Novo Nordisk's semaglutide are now available at lower prices. ...- Firms plan 9.1% pay hike in 2026 amid skills-focused shift, says reportIndia Inc. anticipates a 9.1% salary increase in 2026. Global Capability Centres will lead with 10.4% growth. Financial services and e-comm...
- Pay hikes ease to 9.1% in 2026 as firms focus on skill-based rewards: EY reportIndia Inc. anticipates a 9.1% salary increment in 2026, with Global Capability Centers leading at 10.4%. Attrition is normalizing, though v...
- Sun Pharma, Wockhardt & other pharma stocks crack up to 9% as Trump announces 100% tariff on imported patented drugsPharma stocks declined following Donald Trump's tariff announcement. Wockhardt experienced the biggest drop. Sun Pharma also hit a 52-week ...
- Explained: What Dr Trump’s 100% bitter tariff pill means for India’s $10 billion pharma export machineThe US has imposed a 100% tariff on branded and patented pharmaceuticals, targeting imports from India’s $10 billion export industry. While...
- In major move, patent of Novartis' blockbuster cardiac drug revoked by IndiaThe Indian Patent Office revoked Novartis' patent for Vymada, a heart failure drug, citing a lack of novelty and inventive step. This decis...
- From Paytm to Eternal: 42 stocks India's top performing PMS fund managers are betting onIndia’s top-performing PMS funds placed bold bets in July across 42 stocks, spanning fintech giants, healthcare disruptors, agrochemicals, ...
- Obesity lab: India becomes ground zero for weight-loss drug raceIndia is emerging as a key player in the global weight management industry, driven by a rising obesity crisis and the impending patent expi...
- India houses more than half of the world’s GCCs: ReportIndia, home to 53% of global GCCs, is witnessing a surge in these centers, driven by competitive costs and a skilled workforce. While Tier-...
- G7 in Canada: What’s at stake for Canada as Carney hosts Trump, Modi, Zelenskyy amid trade wars, global crisis, and tensionsCanada is preparing to host the G7 summit. Prime Minister Mark Carney aims to reshape Canada's global image. Discussions will include trade...
- TiEcon 2025: Unveiling the themes of Silicon Valley’s premier AI eventThe upcoming TiEcon event in Silicon Valley, California, scheduled from April 30-May 2, features 11 industry tracks that dive deep into the...
- Pharma stocks in focus as Trump signals tariffs on imported medicinesPresident Trump announced potential tariffs on imported pharmaceuticals, impacting countries like India, a major supplier to the US drug ma...
- India Inc on the Move 2025: AI-powered innovation to drive smart and sustainable manufacturingIndia's manufacturing sector is evolving with initiatives like Make in India aiming to boost its GDP contribution. The sixth edition of Ind...
- Dr. Reddy’s shares fall 6%, Aurobindo Pharma 10% as Trump signals 25% tariffs on pharma importsDr. Reddy’s Laboratories fell 5.8% to Rs 1,128.90, while Zydus Lifesciences dropped 4.8%. Sun Pharma, India's largest drugmaker, declined b...
- Tata 1mg’s FY24 report; Cognizant-Wipro CFO lawsuit settledEpharmacy Tata 1mg reported a 21% rise in revenue to Rs 1,968 crore for FY24. This and more on today’s ETtech Top 5.
- Biotech firm Vyome Therapeutics to go public via reverse merger with Nasdaq-listed Reshape LifesciencesVyome Therapeutics, a biotech company backed by Manipal group chief Ranjan Pai, will go public in the US through a reverse merger with US-b...
- Empowering healthcare innovations: Dr. Noura Khamis Al Ghaithi on ADGHW's role in global healthcare collaborationH.E. Dr. Noura Khamis Al Ghaithi discusses ADGHW as a platform for global healthcare collaboration, focusing on innovations and partnership...
- ICICI Pru Multicap mutual fund review: In portfolio reshaping modeLast year, this mutual fund had to quickly realign a fifth of its portfolio to adhere to the revised asset allocation norms for multi-cap f...
- Billionaire families reshape Silicon Valley’s venture terrainOver 70% of billionaire families in Asia are investing in venture, which is higher than what's being seen in the U.S. and Europe, where tha...
Load More
